Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Asian Pac J Cancer Prev ; 13(9): 4335-9, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-23167339

RESUMO

BACKGROUND: Whether sirolimus is useful in the prevention of non-melanoma skin cancer (NMSC) remains unclear and we therefore performed this meta-analysis of randomized controlled trials to test the hypothesis that Sirolimus-based immunosuppression is associated with a decrease in NMSC. METHODS: The main outcomes were NMSC, squamous-cell carcinoma and basal-cell carcinoma. The pooled risk ratio (RR) with its 95% confidence interval (95%CI) were used to assess the effects. RESULTS: 5 randomized trials involving a total of 1499 patients receiving kidney transplantation were included. Patients undergoing Sirolimus-based immunosuppression had much lower risk of NMSC (RR = 0.49, 95%CI 0.32-0.76, P = 0.001). Subgroup analyses by tumor type showed that Sirolimus-based immunosuppression significantly decreased risk of both squamous-cell carcinoma (RR = 0.58, 95%CI 0.43-0.78, P < 0.001) and basal-cell carcinoma (RR = 0.56, 95%CI 0.37-0.85, P = 0.006). The quality of evidence was high for NMSC, and moderate for squamous-cell carcinoma and basal-cell carcinoma. No evidence of publication bias was observed. CONCLUSION: High quality evidence suggests that Sirolimus-based immunosuppression decreases risk of non-melanoma skin cancer, and Sirolimus has an antitumoral effect among kidney-transplant recipients.


Assuntos
Carcinoma Basocelular/prevenção & controle , Carcinoma de Células Escamosas/prevenção & controle , Terapia de Imunossupressão/efeitos adversos , Imunossupressores/uso terapêutico , Sirolimo/uso terapêutico , Neoplasias Cutâneas/prevenção & controle , Carcinoma Basocelular/etiologia , Carcinoma de Células Escamosas/etiologia , Humanos , Transplante de Rim/efeitos adversos , Neoplasias Cutâneas/etiologia
2.
Zhongguo Zhong Yao Za Zhi ; 30(16): 1246-8, 2005 Aug.
Artigo em Chinês | MEDLINE | ID: mdl-16245899

RESUMO

OBJECTIVE: To study the possibility of hyaluronic acid as densifier of Shuanguangliao eye-drops. METHOD: The factors related with hyaluronic acid s viscosity, such as pH-value and storing temperature, are tested in this experiment. At the same time, we checked the stimulation, stability of the densifier. RESULT: There was not effect on viscosity of pH-value and storing temperature. No stimulation on the eye was found after densified with hyaluronic acid. The viscosity properties of hyaluronic acid are stablile. CONCLUSION: The hyaliuronic acid added to Shuanghuanglian eye-drops are stabiliable and it can be applied in eye-drops. The increased viscosity is benefit to extend the residence time of drug in eye.


Assuntos
Antibacterianos/administração & dosagem , Medicamentos de Ervas Chinesas/administração & dosagem , Ácido Hialurônico , Soluções Oftálmicas/administração & dosagem , Plantas Medicinais , Animais , Antibacterianos/isolamento & purificação , Portadores de Fármacos , Combinação de Medicamentos , Medicamentos de Ervas Chinesas/isolamento & purificação , Olho/efeitos dos fármacos , Feminino , Ácido Hialurônico/farmacologia , Ácido Hialurônico/toxicidade , Concentração de Íons de Hidrogênio , Masculino , Soluções Oftálmicas/isolamento & purificação , Plantas Medicinais/química , Coelhos , Temperatura , Viscosidade/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA